IP Library Granted Patent US 11,173,138
Granted Patent B2
US 11,173,138 · App. 15/491,924 · Granted Nov 16, 2021

Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans

Inventors: Ryan Lowery (Tampa, FL); Jacob Wilson (Tampa, FL)
Assignee: Keto Patent Group, Inc.
A61K31/22A61K31/047A61K31/19A61K31/198A61K45/06A61K47/06A61K47/183A61K2121/00A61K2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,173,138
App. No.
15/491,924
Granted
Nov 16, 2021
Kind
B2
Abstract

In various implementations, beta-hydroxybutyrate, related compounds, and/or one or more other compounds may be administered to an individual to cause weight loss, weight maintenance, elevate blood ketone levels, maintain blood ketone levels, reduce blood glucose levels, maintain blood glucose levels, improve energy, focus, mood, cognitive function, or aide with neurological or inflammatory disorders and/or combinations thereof. Other compounds may include short chain fatty acids, short chain triglycerides, medium chain fatty acids, medium chain triglycerides, long chain fatty acids, long chain triglycerides, berberine, metabolites of berberine (e.g., dihydroberberine), and/or combinations thereof.

Claims (36)

1. A method for maintaining or increasing weight loss in an individual, the method comprising:

orally administering a composition, wherein the composition consisting of:

approximately 0.5 g to approximately 10 g of R-beta-hydroxybutyrate, wherein the R-beta-hydroxybutyrate comprises one or more salts of R-beta-hydroxybutyrate salt;

at least one amino acid; and

optionally, of at least one of a flavoring, a vitamin, a mineral, or a binder;

wherein administration induces or maintains ketosis in an individual.

2. The method of claim 1 wherein the amount of R-beta-hydroxybutyrate salt comprises approximately 0.5 to approximately 3 g of R-beta-hydroxybutyrate salt.

3. The method of claim 1 wherein at least one of the amino acids in the composition comprises leucine.

4. The method of claim 1 wherein at least one of the amino acids in the composition comprises leucine, and wherein the amount of leucine in the composition comprises approximately 0.5 to approximately 2 g leucine.

5. The method of claim 1 wherein at least one of the amino acids in the composition comprises leucine, and wherein the amount of leucine in the composition comprises approximately 1 to approximately 3 g leucine.

6. The method of claim 1 wherein at least one of the amino acids and a portion of the R-beta-hydroxybutyrate of the composition are an R-beta-hydroxybutyrate-amino acid complex.

7. The method of claim 1 wherein administration of the composition increases mental acuity.

8. The method of claim 1 wherein the composition is administered up to 5 times daily.

9. The method of claim 1 wherein one or more of the salts of R-beta-hydroxybutyrate salt comprise at least one of sodium R-beta-hydroxybutyrate, potassium R-beta-hydroxybutyrate, magnesium R-beta-hydroxybutyrate, or calcium R-beta-hydroxybutyrate salt.

10. The method of claim 1 wherein administration of the composition increases at least one of metabolism, fat loss, fat oxidation, motor function, or muscle mass.

11. A method for maintaining or inducing ketosis in an individual, the method comprising:

orally administering a composition, wherein the composition consisting of:

0.5 g to approximately 10 g of R-beta-hydroxybutyrate, wherein the R-beta-hydroxybutyrate comprises one or more salts of R-beta-hydroxybutyrate salt; and

at least one amino acid; and

optionally, at least one of a flavoring, a vitamin, a mineral, or a binder;

wherein administration induces or maintains ketosis in an individual.

12. The method of claim 11 wherein the amount of R-beta-hydroxybutyrate salt comprises approximately 0.5 to approximately 3 g of R-beta-hydroxybutyrate salt.

13. The method of claim 11 wherein at least one of the amino acids in the composition comprises leucine.

14. The method of claim 11 wherein at least one of the amino acids in the composition comprises leucine, and wherein the amount of leucine in the composition comprises approximately 0.5 to approximately 3 g leucine.

15. The method of claim 11 wherein administration of the composition increases at least one of metabolism, fat loss, fat oxidation, motor function, or muscle mass.

16. A method for maintaining ketosis in an individual, the method comprising:

orally administering a composition, wherein the composition consisting of:

beta-hydroxybutyrate, wherein the beta-hydroxybutyrate consists essentially of:

at least one polymer of beta-hydroxybutyrate; and

0.5 g to approximately 10 g of at least one salt of R-beta-hydroxybutyrate;

and optionally at least one of a flavoring, a vitamin, a mineral, or a binder,

wherein administration induces or maintains ketosis in an individual.

17. The method of claim 16 wherein the administration of the composition maintains or increases weight loss.

18. The method of claim 16 wherein the at least one of the R-beta-hydroxybutyrate salts comprises at least one of sodium R-beta-hydroxybutyrate, potassium R-beta-hydroxybutyrate, calcium R-beta-hydroxybutyrate, or magnesium R-beta-hydroxybutyrate.

19. The method of claim 16 wherein administration of the composition increases at least one of metabolism, fat loss, fat oxidation, motor function, or muscle mass.

20. The method of claim 16 wherein administration of the composition increases mental acuity.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2023
From: LOWERY, RYAN P.; WILSON, JACOB
To: AXCESS GLOBAL SCIENCES, LLC
Reel/Frame 063450/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2023
From: KETO PATENT GROUP, INC.
To: AXCESS GLOBAL SCIENCES, LLC
Reel/Frame 063319/0822 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2021
From: WELLS, SHAWN
To: KETO PATENT GROUP, INC.
Reel/Frame 058311/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2019
From: LOWERY, RYAN; WILSON, JACOB; UNDERWOOD, BRIAN; LACORE, TERRY
To: KETO PATENT GROUP, INC.
Reel/Frame 050629/0785 →
Continuity (2)
Provisional Application 62324798 · Apr 19, 2016
Related Publication 20170296501A1 · Oct 19, 2017
Cited By (15)
US 12,186,297 US 12,251,362 US 12,329,734 US 12,350,243 US 12,396,974 US 12,433,912 US 12,439,945 US 12,496,283 US 12,521,378 US 12,533,331 US 12,533,346 US 12,551,455 US 12,599,579 US 12,622,889 US 12,703,842